Healthcare trends

The Global  Musculoskeletal System Disorders Market  is projected to register a  CAGR of 5.3%  to reach an estimated  USD 5.73 billion  by 2025. The growth of global musculoskeletal system disorders market is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are  expected to curb the growth of the global musculoskeletal system disorders market. The rising number of cases of work-related musculoskeletal system disorders in developing nations and an increase in the geriatric population in developed nations are driving the growth of the market.   Musculoskeletal System Disorders Market Key Players: Some of the key players in the global  musculoskeletal system disorders market  are AB Science (France) AbGenomics International Inc. (US) Alder BioPharmaceuticals,Inc. (US) Amgen Inc. (US) Lexicon Pharmaceuticals, Inc. (US) LG

Medical Marijuana Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Medical Marijuana Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Industry Synopsis: Global  Medical Marijuana Market  is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023. Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions. Marijuana consists of chemical components cannabinoids,  which can be used as medicine to treat the symptoms caused by illness. Medical marijuana plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising accepta

According to Latest study of MRFR, Biosensors Market Development and Demand Forecast to 2020 On Path to Achieve A CAGR of 9.6 % and set to profit from Surge in Healthcare Industry Development. Analysis The increased integration of technology in healthcare is promoting the use of Biosensorss favorably. Reports that appraise the healthcare industry have been presented by Market Research Future, which creates reports on industry verticals that assess the Biosensor market development and projections. The market is anticipated to perceive a CAGR of 9.6 % approximately from 2014 to 2020. Table of Content Chapter 3. Market Outlook          3.1           Introduction       3.2           Trends in the Market      3.2.1       Rising product innovation              3.2.2       Technological advancement of Biosensorss leading to miniaturizations of sensors                3.3           Opportunities in the Market         3.3.1       Opportunity from increasing demand o

Market Research Future published a research report on Non-Invasive Prenatal Testing (NIPT) Market Research Report - Global Forecast till 2025. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions. According to MRFR analysis, the global  Non-Invasive Prenatal Testing Market  is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018. Non-Invasive Prenatal Testing (NIPT) Market  Overview NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition. These devices and procedures are used for applications. As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100

Behavioral Health Services Market Research Report - Global Forecast till 2025 Behavior health services provide services to patients with mental health disorders, substance abuse disorders, and other mental disorders. Behavioral health includes conditions such as depression, anxiety, substance abuse, and others. Around 83% people in the US are suffering from behavioral health issues. According to Japanese study around 298 people were suffering from various behavioral disorders in  2018 . The growth of the global behavioral health services market is driven by various factors such as an increasing global geriatric population, rising prevalence of the depressive disorder, and poor fitness levels. However, high costs of treatment are expected to curb the growth of the global behavioral health services market.   According to MRFR analysis,  Behavioral Health Services Market  is expected to register a  CAGR of 3.4%  during the forecast period of  2019 to 2025  and was valued at  USD 1

Market Highlights According to MRFR analysis,  Biopharmaceuticals Market  is expected to register a  CAGR of 8.99%  during the forecast period of  2019 to 2025  and was valued at  USD 238,192.7 million in 2018. Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells. The global biopharmaceuticals market is growing owing to various factors such as increasing investment by major companies on research & development of biopharmaceuticals and increasing acceptance for biopharmaceuticals due to their ability to treat the previously untreatable diseases. Furthermore, the number of geriatric populations is, tremendously, the incidence rate of chronic diseases is also high, and technological advancements are growing which are also expected to fuel the market growth. However, the entry of low-cost biosimilars, risk of side

Market Research Future published a research report on Infection Control Market Research Report –Global Forecast to 2023.Report gives a clear picture of current market scenario which includes past and estimated future market size Infection Control Market Overview The use of clinical trials for pinpointing causes of hospital acquired infections (HAIs) in hospitals is likely to affect the market demand significantly. According to the University of Michigan, close to 2 million infections occur in national hospitals. Development of infection control products as well as its subsequent adoption by hospitals can fuel the market revenue. For instance, the Surfacide Helios system which emits ultraviolet (UV-C) energy for detecting the presence of bacterial infections. Infection Control Market Segmentation: The global infection control market has been segmented on the basis of type and end-user. On the basis of type, the global infection control market can be segmented into

Market Highlights The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, gynandroblastoma, Sex Cord Tumor with Annular Tubules (SCTAT), and Sertoli Leydig cell tumor. In humans, this type of tumor accounts for 8% of the ovarian cancers and around 5% of testicular cancers. It is noted that the increasing cases of ovarian and testicular cancer, technological advancements, and increasing healthcare expenditure are the key factors driving the  sex cord gonadal stromal tumor market .  Various other factors such as the growing awareness about the cord-gonadal stromal tumor, unmet medical needs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement are continuously contrib